Overview
IRON market data
Price History
No market bars yet for IRON. This page will populate once the next provider sweep lands.
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for IRON. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
8-K filing — Disc Medicine, Inc. (IRON)SEC EDGAR · Jun 30, 2026, 8:16 PM
Morgan Stanley Maintains Overweight on Disc Medicine, Raises Price Target to $85Benzinga · Jun 16, 2026, 1:35 PM
Disc Medicine Completes FDA Type A Meeting Regarding The Complete Response Letter To The New Drug Application For Bitopertin In Erythropoietic Protoporphyria; Data From APOLLO Phase 3 Study Expected In Q4 2026Benzinga · Jun 9, 2026, 12:40 PM
Disc Medicine Presents Updated Data From Myelofibrosis And Anemia Treatment RALLY-MF Phase 2 Trial Showing Reductions In Hepcidin And Higher Iron Levels, A Positive Clinical Impact On Anemia Measures Across A Broad Range Of Patient TypesBenzinga · Jun 2, 2026, 12:07 PM
Morgan Stanley Maintains Overweight on Disc Medicine, Raises Price Target to $80Benzinga · May 14, 2026, 5:00 PM